You are here: Industry Insights > acquisition

News List

Astellas acquires Quethera for up to £85M biospectrumasia
August 13, 2018
Through this transaction, Astellas has acquired Quethera's ophthalmic gene therapy program, which uses a recombinant adeno-associated viral vector system (rAAV) to introduce therapeutic genes into target retinal cells for the treatment of glaucoma.
Varian acquires HumediQ Global GMbH biospectrumasia
August 08, 2018
This acquisition expands Varian's motion-management portfolio and is part of the company's long-term growth and value creation strategy.
Takeda closes TiGenix acquisition for about $608m pharmaceutical-technology
August 03, 2018
Takeda Pharmaceutical has completed its purchase of all outstanding ordinary shares of Belgium-based TiGenix for approximately $608.84m (€520m), representing €1.78 per share.
Cipla to acquire South African drug firm for $33M biospectrumasia
July 16, 2018
The drugmaker will acquire Mirren through wholly owned unit Cipla Medpro South Africa.
Eli Lilly closes $1.6bn ARMO BioSciences acquisition pharmaceutical-technology
June 28, 2018
Eli Lilly has completed the acquisition of immuno-oncology company ARMO BioSciences in an all-cash deal valued at nearly $1.6bn.
Bio-Techne to acquire Exosome Diagnostics biospectrumasia
June 27, 2018
The transaction will be financed through a combination of cash on hand and a revolving line of credit facility that Bio-Techne expects to obtain prior to the closing of the acquisition.
Shanghai Kinetic to acquire Elliquence for $77 M biospectrumasia
June 14, 2018
About 52 per cent of Elliquence's revenues are from China.
Agilent to acquire assets of Ultra Scientific biospectrumasia
June 01, 2018
The acquisition will help in significant expansion of Agilent's certified reference materials and chemical standards business
Agilent completes acquisition of Genohm biospectrumasia
May 16, 2018
This acquisition enhances Agilent’s current software portfolio
Lilly to acquire AurKa Pharma biospectrumasia
May 16, 2018
Acquisition Expands Lilly Oncology Pipeline with Early-Phase Asset Being Studied in Multiple Tumor Types

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page